Association between adenomas of rectosigmoid colon and metabolic syndrome features in a Chinese population

Journal of Gastroenterology and Hepatology (Australia)

Volumn 20, Issue 9, 2005, Pages 1410-1415

  Wang, Ya Yu ^a   Lin, Shih Yi ^a   Lai, Wen An ^a   Liu, Pi Hwa ^a   Sheu, Wayne Huey Herng ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Metabolic syndrome; Rectosigmoid adenomas

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BENIGN TUMOR; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; COLON ADENOMA; COLON POLYP; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; HYPERPLASIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PHYSICAL EXAMINATION; POLYPECTOMY; PRECANCER; PRIORITY JOURNAL; RISK FACTOR; SIGMOIDOSCOPY; TAIWAN; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ADENOMA; AGE; AGED; COLON TUMOR; MIDDLE AGED; PREVALENCE; RECTUM TUMOR; SEX DIFFERENCE;

ADENOMA; ADULT; AGE FACTORS; AGED; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RECTAL NEOPLASMS; SEX FACTORS; SIGMOID NEOPLASMS; TAIWAN;

EID: 33644643661     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.03971.x     Document Type: Article

References (39)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988 37 : 1595 607.
2. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin resistance syndrome (syndrome X). Diabetes 1992 41 : 715 22.
3. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am. J. Cardiol. 1999 83 : 25F 9F.
4. Lakka HM, Laaksonen DE, Lakka TA et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002 288 : 2709 16.
5. Alexander CM, Landsman PB, Teutsch SM, Haffer SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003 52 : 1210 14.
6. Sattar N, Gaw A, Scherbakova O et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease in the West of Scotland Coronary Prevention Study. Circulation 2003 108 : 414 19.
7. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the third National Health and Nutritional Examination Survey, 1988-1994. Arch. Intern. Med. 2003 163 : 427 36.
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 285 : 2486 96.
9. Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol. Clin. North Am. 2002 31 : 925 43.
10. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J. Nutr. 2001 131 : S3109 20.
11. Chang CK, Ulrich CM. Hyperinsulinemia and hyperglycemia: possible risk factors of colorectal cancer among diabetic patients. Diabetologia 2003 46 : 595 607.
12. Hu FB, Manson JE, Liu S et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J. Natl. Cancer Inst. 1999 91 : 542 7.
13. Schoen RE, Tangen CM, Kuller LH et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J. Natl. Cancer Inst. 1999 91 : 1147 54.
14. Will JC, Gasluska DA, Vincor F, Calle EE. Colorectal cancer: another complication of diabetes mellitus? Am. J. Epidemiol. 1998 147 : 816 25.
15. Ford ES. Body mass index and colon cancer in a national sample of adult US men and women. Am. J. Epidemiol. 1999 150 : 390 8.
16. O'Brien MJ, Winawer SJ, Zauber AG et al. The national polyp study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990 98 : 371 9.
17. Pan WH, Flegal KM, Chang HY et al. BMI and obesity-related metabolic disorders between Taiwanese and US Whites and Blacks. Am. J. Clin. Nutr. 2004 79 : 31 9.
18. Kanazawa M, Yoshiike N, Osaka T, Numba Y, Zimmet P, Inoue T. Criteria and classification of obesity in Japan and Asia-Oceania. Asia Pac. J. Clin. Nutr. 2002 11 (Suppl. 8 S732 7.
19. Bird CL, Ingles SA, Frankl HD, Lee ER, Longnecker MP, Haile RW. Serum lipids and adenomas of left colon and rectum. Cancer Epidemiol. Biomarkers Prev. 1996 5 : 607 12.
20. Bird CL, Frankl HD, Lee ER, Haile RW. Obesity, weight gain, large weight change, and adenomatous polyps of the left colon and rectum. Am. J. Epidemiol. 1998 147 : 670 80.
21. Gupta K, Krishnaswamy G, Karnad A, Peiris AN. Insulin: a novel factor in carcinogenesis. Am. J. Med. Sci. 2002 323 : 140 5.
22. Tran TT, Medline A, Bruce WR. Insulin promotion of colon tumors in rats. Cancer Epidemiol. Biomarkers Prev. 1996 5 : 1013 15.
23. Corpet DE, Jacqinet C, Peifer G, Tache S. Insulin injections promote the growth of aberrant crypt foci in the colon of rats. Nutr. Cancer 1997 27 : 316 20.
24. Copeland GP, Cleinster SJ, Davis JC, Hipkins LJ. Insulin resistance in patients with colorectal cancer. Br. J. Surg. 1987 74 : 1031 6.
25. Yam D, Fink A, Mashiah A, Ben-Hur E. Hyperinsulinemia in colon, stomach and breast cancer patients. Cancer Lett. 1996 104 : 129 32.
26. Kaaks R, Toniolo P, Akhmedkhanov A et al. Serum C-peptide, insulin-like growth factor (IGF)-1, IGF-binding protein, colorectal cancer in women. J. Natl. Cancer Inst. 2000 92 : 1592 600.
27. Hanley AJ, Wagenknecht LE, D'Agostino PB Jr, Zinman B, Haffer SM. Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome. Diabetes 2003 52 : 2740 7.
28. Lorenzo C, Okoloise M, Williams K, Stem MP, Haffer SM. The metabolic syndrome as an another predictor of type 2 diabetes: the San Antonio Heart Study. Diabetes Care 2003 26 : 3153 9.
29. Trevisan M, Liu J, Muti P et al. Markers of insulin resistance and colorectal mortality. Cancer Epidemiol. Biomarkers Prev. 2001 10 : 937 41.
30. Colangelo LA, Capstur SM, Gann PH, Dyer AR, Liu K. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol. Biomarkers Prev. 2002 11 : 385 91.
31. Moller DE, Flier JS. Insulin resistance mechanisms, syndromes, and implications. N. Engl. J. Med. 1991 325 : 938 48.
32. Angelin B, Leijd B, Hulterantz R, Einarsson K. Increased turnover of very low density lipoprotein triglyceride during treatment with cholestyramine in familial hypercholesterolemia. J. Intern. Med. 1990 227 : 201 6.
33. Hill MJ. Bile flow and colon cancer. Mutat. Res. 1990 238 : 201 6.
34. Frohlich M, Imhof A, Berg A et al. Association between C-reactive protein and features of the metabolic syndrome. Diabetes Care 2000 23 : 1835 9.
35. Ford ES. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 2003 168 : 351 8.
36. Katsuki A, Sumida Y, Murashima S et al. Serum levels of tumor necrosis factor-α are increased in obese patients with non-insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 1998 83 : 859 62.
37. Kern AP, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2001 280 : E745 51.
38. Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ. C-reactive protein and the risk of incident colorectal cancer. JAMA 2004 291 : 585 90.
39. Jass JR. Hyperplastic polyps of the colorectum: innocent or guilty? Dis. Colon Rectum 2001 44 : 163 6.